Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2016-12-31 | 2013-12-31 | 2011-12-31 | 2011-03-31 | 2010-12-31 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-03-31 | 2007-12-31 | 2007-06-30 | 2007-03-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||||||
net income | 21,513,000 | 21,021,000 | 22,426,000 | 18,215,000 | 19,953,000 | 20,713,000 | 20,707,000 | 19,546,000 | 17,603,000 | 15,908,000 | 22,193,000 | 25,433,000 | 17,147,000 | 15,845,000 | 16,140,000 | 17,015,000 | 15,981,000 | 23,009,000 | 25,002,000 | 13,578,000 | 26,840,000 | 17,257,000 | 25,642,000 | 19,610,000 | 16,024,000 | 8,459,000 | 2,224,000 | -7,348,000 | 10,237,000 | 2,922,000 | 8,926,000 | 10,036,000 | 5,761,000 | 11,488,000 | 14,823,000 | 18,816,000 | -17,257,000 | 11,987,000 | 15,831,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||
esop and stock-based compensation expense | 2,343,000 | 2,345,000 | 2,349,000 | 2,376,000 | 2,203,000 | 2,603,000 | 2,321,000 | 2,402,000 | 2,380,000 | 2,587,000 | 2,631,000 | 2,572,000 | 2,544,000 | 2,798,000 | 3,095,000 | 3,231,000 | 3,464,000 | 3,648,000 | 3,368,000 | 2,802,000 | 2,739,000 | 3,293,000 | 3,283,000 | 3,071,000 | 2,847,000 | 2,968,000 | 2,915,000 | 1,850,000 | 3,621,000 | 3,245,000 | 3,066,000 | ||||||||
depreciation and amortization | 5,947,000 | 5,554,000 | 5,309,000 | 4,959,000 | 4,979,000 | 4,515,000 | 4,581,000 | 4,728,000 | 4,651,000 | 4,527,000 | 4,209,000 | 6,227,000 | 6,700,000 | 6,915,000 | 7,193,000 | 3,455,000 | 8,806,000 | 10,476,000 | 9,831,000 | 9,940,000 | 8,392,000 | 6,694,000 | 7,794,000 | 5,787,000 | 3,129,000 | 6,047,000 | 4,346,000 | 7,779,000 | 3,907,000 | 3,664,000 | 3,992,000 | 6,741,000 | 6,364,000 | 2,463,000 | 2,577,000 | 1,668,000 | 1,940,000 | 1,854,000 | 1,341,000 |
deferred income taxes | 8,000 | 30,000 | -10,000 | 2,902,000 | -82,000 | -93,000 | -25,000 | 3,906,000 | -19,000 | -110,000 | -45,000 | -25,883,000 | -534,000 | -462,000 | 3,000 | -13,898,000 | -737,000 | 623,000 | -237,000 | 20,585,000 | 1,399,000 | -118,000 | -64,000 | 0 | 0 | 800,000 | |||||||||||||
provision (release) for credit losses | -1,500,000 | 1,000,000 | -500,000 | -1,000,000 | -1,000,000 | 500,000 | 0 | -1,000,000 | -1,000,000 | 0 | 4,000,000 | -1,000,000 | -2,000,000 | -2,000,000 | -1,000,000 | -4,000,000 | -2,000,000 | ||||||||||||||||||||||
net gain on the sale of loans | -726,000 | -1,187,000 | -1,115,000 | -1,101,000 | -723,000 | -442,000 | -481,000 | 119,000 | -21,000 | -579,000 | -17,000 | 1,113,000 | 51,000 | -113,000 | -2,187,000 | -4,305,000 | -3,423,000 | -8,911,000 | -16,443,000 | -11,536,000 | -10,844,000 | -3,138,000 | -2,925,000 | -883,000 | -339,000 | -271,000 | 0 | -19,710,000 | -2,781,000 | -2,968,000 | |||||||||
other net (gains) losses | 0 | 0 | -19,000 | 46,000 | -9,000 | 239,000 | 26,000 | 17,000 | 58,000 | -300,000 | 258,000 | 353,000 | 0 | 199,000 | 578,000 | -282,000 | 388,000 | 5,000 | |||||||||||||||||||||
proceeds from sales of loans held for sale | 19,692,000 | 8,595,000 | 34,970,000 | 46,954,000 | 50,385,000 | 12,957,000 | 4,369,000 | 8,305,000 | 17,965,000 | 10,155,000 | 6,699,000 | 14,959,000 | 498,000 | 15,584,000 | 10,454,000 | 17,116,000 | 15,013,000 | 20,215,000 | 11,569,000 | 21,310,000 | 13,696,000 | 17,639,000 | 9,753,000 | ||||||||||||||||
loans originated and principal repayments on loans for sale | -24,785,000 | -9,821,000 | -22,716,000 | -65,613,000 | -20,668,000 | -2,123,000 | -14,342,000 | -9,922,000 | -9,676,000 | -1,846,000 | 6,168,000 | -23,460,000 | |||||||||||||||||||||||||||
increase in bank owned life insurance contracts | -2,736,000 | -2,825,000 | -2,548,000 | -2,311,000 | -2,254,000 | -2,193,000 | -3,191,000 | -2,835,000 | -2,159,000 | -2,123,000 | -2,238,000 | -2,127,000 | -2,092,000 | -2,077,000 | -2,136,000 | -2,118,000 | -2,052,000 | -1,662,000 | -1,559,000 | -1,551,000 | -1,577,000 | -1,607,000 | -1,619,000 | -1,586,000 | -1,640,000 | ||||||||||||||
net decrease in interest receivable and other assets | -1,372,000 | -1,507,000 | 10,109,000 | 3,091,000 | 6,302,000 | 1,951,000 | 4,811,000 | -2,062,000 | 10,855,000 | 10,013,000 | 2,395,000 | ||||||||||||||||||||||||||||
net increase in accrued expenses and other liabilities | 5,368,000 | -2,480,000 | -1,710,000 | -79,731,000 | 86,751,000 | -2,826,000 | 8,969,000 | 3,929,000 | 13,289,000 | -43,694,000 | 62,971,000 | 5,246,000 | -1,467,000 | -38,109,000 | 50,667,000 | 3,217,000 | -871,000 | 7,459,000 | 1,813,000 | -416,000 | 16,066,000 | 50,570,000 | 48,853,000 | 55,006,000 | 47,349,000 | 4,612,000 | -50,363,000 | 50,146,000 | 7,883,000 | -46,466,000 | 48,892,000 | 53,983,000 | 9,399,000 | ||||||
net cash from operating activities | 26,752,000 | 21,225,000 | 45,545,000 | -58,680,000 | 96,743,000 | 14,211,000 | 36,326,000 | 13,826,000 | 33,770,000 | -35,684,000 | 78,810,000 | -12,184,000 | 10,443,000 | 33,013,000 | 7,657,000 | -38,208,000 | 77,430,000 | 19,755,000 | 24,178,000 | 30,401,000 | 28,860,000 | 33,146,000 | 29,391,000 | 97,156,000 | 80,592,000 | 91,422,000 | -34,081,000 | 85,715,000 | -10,677,000 | 11,092,000 | -1,876,000 | -24,779,000 | -47,453,000 | 119,642,000 | -28,125,000 | 82,735,000 | 172,860,000 | 10,656,000 | 202,755,000 |
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||
loans originated | -1,092,530,000 | -820,643,000 | -799,167,000 | -762,010,000 | -581,483,000 | -769,865,000 | -963,356,000 | -694,222,000 | -857,810,000 | -1,148,866,000 | -1,616,745,000 | -1,301,305,000 | -1,206,814,000 | -1,110,512,000 | -1,098,149,000 | -1,194,714,000 | -1,471,386,000 | -1,112,695,000 | -1,173,829,000 | -913,485,000 | -1,055,571,000 | -866,302,000 | -535,266,000 | -821,282,000 | -471,828,000 | -1,162,813,000 | -688,175,000 | -591,762,000 | -527,250,000 | -819,118,000 | -1,983,270,000 | -638,315,000 | -583,526,000 | -751,641,000 | -700,352,000 | -345,722,000 | -566,006,000 | ||
principal repayments on loans | 810,905,000 | 734,446,000 | 733,146,000 | 731,821,000 | 708,209,000 | 622,352,000 | 649,526,000 | 736,917,000 | 635,345,000 | 606,445,000 | 626,555,000 | 794,951,000 | 850,040,000 | 807,734,000 | 994,804,000 | 1,109,109,000 | 1,100,394,000 | 1,175,873,000 | 1,371,385,000 | 1,195,831,000 | 1,071,051,000 | 699,840,000 | 583,081,000 | 618,202,000 | 437,672,000 | 539,416,000 | 395,994,000 | 625,397,000 | 564,342,000 | 487,422,000 | 351,264,000 | 448,091,000 | 1,450,052,000 | 280,637,000 | 200,152,000 | 465,984,000 | 370,593,000 | 502,600,000 | 207,479,000 |
proceeds from sales, principal repayments and maturities of: | |||||||||||||||||||||||||||||||||||||||
securities available for sale | 26,612,000 | 21,393,000 | 97,225,000 | 23,403,000 | 21,624,000 | 17,569,000 | 79,120,000 | 21,004,000 | 21,602,000 | 19,016,000 | 21,945,000 | 26,383,000 | 37,907,000 | 41,543,000 | 57,735,000 | 62,318,000 | 78,476,000 | 81,357,000 | 94,915,000 | 95,115,000 | 71,354,000 | 49,522,000 | 52,574,000 | 46,226,000 | 30,015,000 | 517,000 | 1,077,000 | 8,380,000 | 3,227,000 | 901,000 | 3,498,000 | 2,640,000 | 2,326,000 | 1,689,000 | 1,937,000 | 1,956,000 | 3,551,000 | 3,399,000 | 3,643,000 |
proceeds from sale of: | |||||||||||||||||||||||||||||||||||||||
loans | 19,890,000 | 62,936,000 | 47,802,000 | 19,621,000 | 6,410,000 | 15,176,000 | 84,975,000 | 10,617,000 | 5,467,000 | 5,170,000 | 12,381,000 | 9,656,000 | 702,000 | 16,895,000 | 60,418,000 | 99,551,000 | 129,957,000 | 288,914,000 | 221,277,000 | 202,207,000 | 263,625,000 | 99,119,000 | 200,923,000 | 67,467,000 | 11,079,000 | 8,023,000 | 0 | 507,378,000 | 167,085,000 | 122,636,000 | 712,117,000 | 132,244,000 | 184,314,000 | 62,639,000 | |||||
real estate owned | 0 | 0 | 193,000 | 167,000 | 0 | 850,000 | 133,000 | 165,000 | 66,000 | 208,000 | 45,000 | 67,000 | 52,000 | 0 | 310,000 | 0 | 0 | 124,000 | 82,000 | 1,313,000 | 1,201,000 | 530,000 | 635,000 | 2,376,000 | 6,993,000 | 4,661,000 | 3,136,000 | 3,746,000 | 4,212,000 | 4,672,000 | 5,339,000 | 3,843,000 | 3,365,000 | 2,128,000 | |||||
fhlb stock | 7,567,000 | 7,653,000 | 4,522,000 | 3,589,000 | 8,282,000 | 14,335,000 | 26,913,000 | 0 | -14,243,000 | -10,440,000 | -10,125,000 | -23,400,000 | 0 | 0 | 0 | -935,000 | -5,956,000 | -1,279,000 | |||||||||||||||||||||
purchases of: | |||||||||||||||||||||||||||||||||||||||
premises and equipment | -1,726,000 | -6,947,000 | -637,000 | -834,000 | -812,000 | -703,000 | -1,585,000 | -500,000 | -1,963,000 | -837,000 | -384,000 | -281,000 | -211,000 | -506,000 | -518,000 | -1,348,000 | -947,000 | -537,000 | -365,000 | -1,070,000 | -1,014,000 | -723,000 | -874,000 | -546,000 | -1,939,000 | -615,000 | -1,713,000 | -1,146,000 | -956,000 | -892,000 | -1,693,000 | 21,013,000 | -1,596,000 | -2,054,000 | |||||
other | 591,000 | 1,607,000 | 289,000 | 1,052,000 | -294,000 | -119,000 | 3,414,000 | 2,211,000 | 0 | -369,000 | 457,000 | 116,000 | -305,000 | -67,000 | 1,534,000 | 165,000 | 480,000 | 2,504,000 | 29,000 | 563,000 | -136,000 | 478,000 | 16,000 | 139,000 | 334,000 | 152,000 | 276,000 | 2,046,000 | 632,000 | -176,000 | 1,232,000 | -1,311,000 | 1,357,000 | -532,000 | -1,928,000 | -467,000 | -413,000 | -696,000 | |
net cash from investing activities | -264,041,000 | -43,600,000 | -2,725,000 | -111,870,000 | -42,972,000 | 71,970,000 | -41,837,000 | -284,530,000 | -377,172,000 | -98,096,000 | -248,833,000 | -394,985,000 | -806,744,000 | -515,811,000 | -157,555,000 | 92,854,000 | 131,356,000 | 270,326,000 | 52,820,000 | 344,643,000 | 184,205,000 | -129,528,000 | -251,744,000 | -201,797,000 | -95,985,000 | -236,622,000 | 8,979,000 | -434,002,000 | 374,219,000 | 60,959,000 | -96,271,000 | -20,524,000 | 247,756,000 | -183,303,000 | -225,690,000 | -283,154,000 | -512,266,000 | -175,588,000 | -114,142,000 |
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||
net increase in deposits | -51,844,000 | 192,205,000 | 14,431,000 | 167,734,000 | 89,299,000 | 11,530,000 | 463,767,000 | 374,889,000 | 66,979,000 | -13,876,000 | 92,037,000 | -237,425,000 | 149,382,000 | -157,157,000 | -87,649,000 | 47,811,000 | -34,954,000 | -4,557,000 | 142,300,000 | 86,891,000 | 234,536,000 | -95,379,000 | -37,372,000 | -58,627,000 | 204,999,000 | 95,793,000 | 36,911,000 | 118,154,000 | 77,672,000 | 40,558,000 | -7,915,000 | 125,158,000 | 132,307,000 | 168,339,000 | 119,417,000 | ||||
net increase in borrowers' advances for insurance and taxes | 26,374,000 | -8,180,000 | 33,705,000 | 30,712,000 | |||||||||||||||||||||||||||||||||||
net increase in principal and interest owed on loans serviced | 10,665,000 | -2,621,000 | -5,821,000 | 13,782,000 | -18,406,000 | -4,766,000 | 4,971,000 | 2,702,000 | -15,767,000 | 34,021,000 | -189,702,000 | 8,027,000 | -3,068,000 | -31,886,000 | 37,190,000 | -1,486,000 | 36,659,000 | -209,000 | 2,154,000 | 970,000 | |||||||||||||||||||
net increase in short-term borrowed funds | 346,000,000 | 33,000,000 | 41,000,000 | -35,000,000 | -100,000,000 | 75,000,000 | -717,000,000 | -101,050,000 | 243,050,000 | 360,000,000 | -85,000,000 | 120,000,000 | 540,000,000 | 249,175,000 | |||||||||||||||||||||||||
proceeds from long-term borrowed funds | 150,000,000 | 0 | 0 | 575,000,000 | 0 | 0 | 0 | 350,000,000 | 200,000,000 | 150,000,000 | 100,000,000 | 150,000,000 | 75,000,000 | 0 | 0 | 100,000,000 | 150,000,000 | 100,000,000 | |||||||||||||||||||||
repayment of long-term borrowed funds | -150,390,000 | -100,457,000 | -175,673,000 | -150,556,000 | -25,438,000 | -150,523,000 | -100,805,000 | -75,644,000 | -493,000 | -597,000 | -1,142,000 | -857,000 | -666,000 | -794,000 | -1,329,000 | -1,008,000 | -888,000 | -1,148,000 | -1,645,000 | -76,109,000 | -40,795,000 | -120,967,000 | -112,239,000 | -18,603,000 | |||||||||||||||
cash collateral/settlements received from (provided to) derivative counterparties | -22,485,000 | -37,906,000 | 58,260,000 | -102,360,000 | 4,993,000 | 47,965,000 | -97,809,000 | 54,583,000 | 102,696,000 | -61,458,000 | -7,677,000 | 36,817,000 | 34,245,000 | 61,918,000 | 29,114,000 | 20,169,000 | 5,111,000 | -12,977,000 | -129,338,000 | 27,921,000 | |||||||||||||||||||
acquisition or net settlement of treasury shares | -744,000 | 0 | -767,000 | -1,000 | |||||||||||||||||||||||||||||||||||
dividends paid to common shareholders | -14,874,000 | -14,898,000 | -14,897,000 | -14,750,000 | -14,704,000 | -14,728,000 | -14,771,000 | -14,561,000 | -14,554,000 | -14,513,000 | -14,666,000 | -14,480,000 | -14,619,000 | -14,479,000 | -14,719,000 | -14,285,000 | -13,984,000 | -14,293,000 | -14,075,000 | -14,029,000 | -14,030,000 | -14,031,000 | -13,375,000 | -6,432,000 | 0 | 0 | -5,201,000 | -5,192,000 | -5,168,000 | -5,238,000 | -5,389,000 | -3,870,000 | |||||||
net cash from financing activities | 226,287,000 | 20,027,000 | -40,607,000 | 73,833,000 | -87,670,000 | -43,615,000 | 90,533,000 | 301,235,000 | 358,489,000 | 111,327,000 | 244,040,000 | 389,203,000 | 813,160,000 | 445,460,000 | 69,581,000 | -146,465,000 | -294,041,000 | -124,601,000 | -75,111,000 | -206,290,000 | -196,267,000 | 127,637,000 | 228,436,000 | 199,813,000 | 46,307,000 | 104,475,000 | -128,399,000 | -52,961,000 | 184,024,000 | 53,994,000 | 67,045,000 | 119,488,000 | -193,746,000 | 23,320,000 | 24,028,000 | 123,055,000 | 41,348,000 | 1,114,560,000 | 114,158,000 |
net increase in cash and cash equivalents | -11,002,000 | -2,348,000 | 2,213,000 | -96,717,000 | -33,899,000 | 42,566,000 | 85,022,000 | 30,531,000 | 15,087,000 | -22,453,000 | 74,017,000 | -17,966,000 | 16,859,000 | -37,338,000 | -80,317,000 | -91,819,000 | -85,255,000 | 165,480,000 | 1,887,000 | 168,754,000 | 16,798,000 | 31,255,000 | 6,083,000 | 95,172,000 | 30,914,000 | -229,787,000 | -77,364,000 | -298,058,000 | 949,628,000 | 202,771,000 | |||||||||
cash and cash equivalents—beginning of period | 0 | 0 | 463,718,000 | 0 | 0 | 466,746,000 | 0 | 0 | 369,564,000 | 0 | 0 | 488,326,000 | 0 | 0 | 498,033,000 | 0 | 0 | 275,143,000 | 231,239,000 | 285,996,000 | 294,846,000 | 0 | 743,740,000 | 0 | 0 | 307,046,000 | 0 | 0 | 132,379,000 | 0 | 829,715,000 | ||||||||
cash and cash equivalents—end of period | -11,002,000 | -2,348,000 | 465,931,000 | -33,899,000 | 42,566,000 | 551,768,000 | 15,087,000 | -22,453,000 | 443,581,000 | 16,859,000 | -37,338,000 | 408,009,000 | -85,255,000 | 165,480,000 | 499,920,000 | 16,798,000 | 31,255,000 | 281,226,000 | 326,411,000 | 316,910,000 | 254,121,000 | -153,501,000 | 342,492,000 | 547,566,000 | 126,045,000 | 275,944,000 | 74,185,000 | 6,557,000 | 92,038,000 | -229,787,000 | 752,351,000 | -298,058,000 | 949,628,000 | 455,698,000 | |||||
supplemental disclosure of cash flow information: | |||||||||||||||||||||||||||||||||||||||
cash paid for interest on deposits | 82,373,000 | 79,108,000 | 82,841,000 | 82,607,000 | 78,545,000 | 74,349,000 | 60,484,000 | 52,901,000 | 49,824,000 | 37,631,000 | 28,797,000 | 22,557,000 | 17,104,000 | 17,326,000 | 19,571,000 | 22,267,000 | 23,082,000 | 25,175,000 | 28,011,000 | 32,078,000 | 33,872,000 | 37,208,000 | 37,729,000 | 22,078,000 | 23,470,000 | 41,464,000 | 44,011,000 | 48,359,000 | 52,012,000 | 51,794,000 | 57,405,000 | 61,764,000 | 65,735,000 | 70,636,000 | 84,386,000 | 95,410,000 | 87,800,000 | 78,117,000 | 83,488,000 |
cash paid for interest on borrowed funds | 47,572,000 | 49,261,000 | 54,439,000 | 57,921,000 | 58,219,000 | 57,972,000 | 62,517,000 | 64,730,000 | 51,813,000 | 42,683,000 | 35,375,000 | 20,433,000 | 8,257,000 | 4,364,000 | 4,066,000 | 3,780,000 | 3,836,000 | 4,093,000 | 4,334,000 | 5,132,000 | 12,232,000 | 16,827,000 | 19,485,000 | 6,499,000 | 1,737,000 | 564,000 | 454,000 | 473,000 | 485,000 | 474,000 | 480,000 | 420,000 | 423,000 | 1,128,000 | |||||
cash paid (received) for interest on interest rate swaps | -13,700,000 | -12,457,000 | -18,173,000 | -21,486,000 | -23,244,000 | -22,351,000 | -15,119,000 | ||||||||||||||||||||||||||||||||
cash paid for income taxes | 4,636,000 | 7,031,000 | 113,000 | 1,957,000 | 3,089,000 | 10,415,000 | 220,000 | 4,332,000 | 5,134,000 | 11,882,000 | 428,000 | 14,186,000 | 11,748,000 | 13,382,000 | 286,000 | 5,759,000 | 10,957,000 | 9,029,000 | 27,000 | 15,000 | 9,000 | 1,628,000 | 21,000 | 218,000 | 508,000 | 4,500,000 | 0 | 4,500,000 | 3,100,000 | 3,300,000 | 5,500,000 | 6,000,000 | 7,500,000 | ||||||
supplemental schedules of noncash investing and financing activities: | |||||||||||||||||||||||||||||||||||||||
transfer of loans to real estate owned | 0 | 280,000 | 294,000 | 59,000 | 236,000 | 1,009,000 | 201,000 | 0 | 73,000 | 289,000 | 0 | 0 | 41,000 | 0 | 0 | 474,000 | 1,277,000 | 1,403,000 | 6,503,000 | 4,109,000 | 6,259,000 | 5,057,000 | -1,159,000 | 6,113,000 | 7,435,000 | 9,472,000 | 4,944,000 | 6,519,000 | 4,832,000 | 6,099,000 | 4,932,000 | 3,515,000 | 2,524,000 | ||||||
transfer of loans from held for investment to held for sale | 39,270,000 | 65,817,000 | 43,702,000 | 17,304,000 | 12,323,000 | 15,726,000 | 84,868,000 | 10,644,000 | 5,433,000 | 5,098,000 | 12,368,000 | 9,922,000 | 723,000 | 923,000 | 74,509,000 | 110,674,000 | 74,797,000 | 236,390,000 | 277,056,000 | 184,613,000 | 297,656,000 | 97,096,000 | 198,694,000 | 66,968,000 | 11,095,000 | ||||||||||||||
transfer of loans from held for sale to held for investment | 0 | 0 | 1,327,000 | 7,754,000 | 0 | 0 | 6,666,000 | 0 | 0 | 0 | 25,027,000 | ||||||||||||||||||||||||||||
treasury stock issued for stock benefit plans | 6,000 | 449,000 | 1,390,000 | 0 | 7,000 | 0 | 5,824,000 | 94,000 | 4,000 | 14,000 | 1,751,000 | 84,000 | 230,000 | 192,000 | 1,906,000 | 10,006,000 | 291,000 | -10,882,000 | 5,895,000 | -8,000 | -176,000 | 928,000 | 32,000 | 749,000 | |||||||||||||||
net decrease in borrowers' advances for insurance and taxes | -32,735,000 | -9,601,000 | -15,324,000 | -28,529,000 | -27,145,000 | -27,970,000 | -2,121,000 | -6,166,000 | -3,937,000 | -5,645,000 | |||||||||||||||||||||||||||||
net decrease in principal and interest owed on loans serviced | 11,886,000 | -9,079,000 | -3,258,000 | -607,000 | 13,302,000 | -10,656,000 | -1,334,000 | -1,413,000 | -2,781,000 | -1,406,000 | -3,440,000 | -570,000 | |||||||||||||||||||||||||||
net gain on sale of commercial property | 0 | -408,000 | 0 | 0 | -4,257,000 | ||||||||||||||||||||||||||||||||||
other net incomees | 43,000 | -500,000 | -13,000 | 224,000 | 679,000 | 415,000 | 3,718,000 | 4,599,000 | 3,591,000 | 2,737,000 | 2,472,000 | 1,984,000 | 411,000 | 1,487,000 | |||||||||||||||||||||||||
loans originated, purchased and principal repayments on loans held for sale | |||||||||||||||||||||||||||||||||||||||
net increase in interest receivable and other assets | -15,658,000 | -5,594,000 | -11,491,000 | -6,617,000 | 7,042,000 | -14,730,000 | -16,078,000 | 5,856,000 | -2,043,000 | -5,705,000 | 7,857,000 | -5,423,000 | -45,699,000 | -21,185,000 | |||||||||||||||||||||||||
loans originated or purchased | |||||||||||||||||||||||||||||||||||||||
premises, equipment and other assets | 0 | 0 | 408,000 | 0 | 0 | 23,512,000 | |||||||||||||||||||||||||||||||||
premises, equipment, and software | |||||||||||||||||||||||||||||||||||||||
proceeds/(repayments) from fed funds purchased | |||||||||||||||||||||||||||||||||||||||
cash and cash equivalents—beginning of year | 0 | 0 | 252,927,000 | ||||||||||||||||||||||||||||||||||||
cash and cash equivalents—end of year | |||||||||||||||||||||||||||||||||||||||
cash (received)/ paid for interest on interest rate swaps | |||||||||||||||||||||||||||||||||||||||
net decrease (increase) in interest receivable and other assets | 1,598,000 | 654,000 | 1,960,000 | 279,000 | 2,728,000 | -7,005,000 | 11,695,000 | 925,000 | |||||||||||||||||||||||||||||||
net increase in fed funds purchased | 0 | -150,000,000 | -75,000,000 | ||||||||||||||||||||||||||||||||||||
acquisition of treasury shares | 0 | -1,918,000 | -342,000 | -4,000 | -713,000 | -4,919,000 | -248,000 | -3,716,000 | |||||||||||||||||||||||||||||||
loans originated and principal repayments on loans held for sale | |||||||||||||||||||||||||||||||||||||||
bank-owned life insurance | 0 | 0 | 0 | -70,000,000 | |||||||||||||||||||||||||||||||||||
cash paid/(received) for interest on interest rate swaps | -4,064,000 | ||||||||||||||||||||||||||||||||||||||
proceeds from fed funds purchased | |||||||||||||||||||||||||||||||||||||||
cash paid for interest on interest rate swaps | 1,112,000 | 6,812,000 | 10,268,000 | 10,946,000 | |||||||||||||||||||||||||||||||||||
net decrease in accrued expenses and other liabilities | -2,735,000 | ||||||||||||||||||||||||||||||||||||||
net decrease in deposits | -60,005,000 | -150,267,000 | -57,397,000 | ||||||||||||||||||||||||||||||||||||
net decrease in short-term borrowed funds | -60,000,000 | -75,102,000 | |||||||||||||||||||||||||||||||||||||
purchase of treasury shares | -321,000 | 1,000 | 0 | -19,000 | -395,000 | -17,670,000 | -26,058,000 | 0 | 0 | 0 | 0 | -1,810,000 | -3,709,000 | -25,519,000 | -60,270,000 | ||||||||||||||||||||||||
acquisition of treasury shares through net settlement | -1,043,000 | ||||||||||||||||||||||||||||||||||||||
increase in cash surrender value for bank owned life insurance contracts | |||||||||||||||||||||||||||||||||||||||
loans originated for sale | -11,669,000 | -19,853,000 | -16,079,000 | -19,515,000 | -9,971,000 | -15,606,000 | -8,438,000 | -7,143,000 | -13,231,000 | 0 | -84,382,000 | -31,757,000 | -86,538,000 | -278,631,000 | -217,154,000 | -153,245,000 | -50,324,000 | -137,834,000 | -42,315,000 | -137,029,000 | -165,787,000 | ||||||||||||||||||
proceeds from principal repayments and maturities of: | |||||||||||||||||||||||||||||||||||||||
acquisition of treasury shares through net settlement of stock benefit plans compensation | -131,000 | -695,000 | -2,945,000 | -107,000 | -221,000 | -1,576,000 | -2,193,000 | ||||||||||||||||||||||||||||||||
cash collateral/settlements received from derivative counterparties | 17,927,000 | ||||||||||||||||||||||||||||||||||||||
provision (credit) for loan losses | 0 | 0 | 6,000,000 | -3,000,000 | |||||||||||||||||||||||||||||||||||
cash collateral/settlements (provided to) received from derivative counterparties | |||||||||||||||||||||||||||||||||||||||
net increase(decrease) in short-term borrowed funds | -283,008,000 | 214,269,000 | -51,093,000 | ||||||||||||||||||||||||||||||||||||
principal repayments on and proceeds from sales of loans held for sale | 4,805,000 | 10,022,000 | 5,290,000 | 0 | 38,226,000 | 64,047,000 | 49,263,000 | 184,349,000 | 186,287,000 | 64,394,000 | 133,025,000 | 113,682,000 | 147,481,000 | 337,539,000 | |||||||||||||||||||||||||
deferred income tax expense | 13,000 | ||||||||||||||||||||||||||||||||||||||
benefit from loan losses | 6,000,000 | 15,000,000 | 22,500,000 | 34,500,000 | 30,000,000 | 25,000,000 | 16,000,000 | 20,000,000 | 28,000,000 | 10,000,000 | 4,500,000 | 3,000,000 | 2,100,000 | 2,250,000 | 2,000,000 | ||||||||||||||||||||||||
cash collateral received from derivative counterparties | 17,702,000 | ||||||||||||||||||||||||||||||||||||||
excess tax benefit related to stock-based compensation | 0 | -16,000 | -1,000 | 0 | 40,000 | 41,000 | |||||||||||||||||||||||||||||||||
net increase in short term borrowed funds | 124,225,000 | 124,633,000 | 99,993,000 | -3,000 | 0 | 5,000 | |||||||||||||||||||||||||||||||||
proceeds from long term borrowed funds | 130,000,000 | ||||||||||||||||||||||||||||||||||||||
repayment of long term borrowed funds | -13,320,000 | 0 | |||||||||||||||||||||||||||||||||||||
excess tax effect related to stock-based compensation | 49,000 | ||||||||||||||||||||||||||||||||||||||
net decrease in borrowers’ advances for insurance and taxes | -2,506,000 | -12,701,000 | -4,761,000 | -124,000 | -18,298,000 | -6,132,000 | -2,035,000 | 53,000 | -1,894,000 | -453,000 | -6,232,000 | ||||||||||||||||||||||||||||
increase in and death benefits for bank owned life insurance contracts | -1,618,000 | -1,623,000 | -1,589,000 | -1,606,000 | -1,646,000 | -1,600,000 | -1,674,000 | -1,623,000 | -1,633,000 | ||||||||||||||||||||||||||||||
securities held to maturity | 55,523,000 | 73,577,000 | 94,393,000 | 84,326,000 | 88,218,000 | 58,257,000 | 94,337,000 | 64,219,000 | 39,601,000 | 75,856,000 | 45,167,000 | 28,452,000 | 17,492,000 | 5,093,000 | |||||||||||||||||||||||||
net increase in borrowers’ advances for insurance and taxes | 3,218,000 | 3,643,000 | |||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -40,725,000 | 6,557,000 | -40,341,000 | ||||||||||||||||||||||||||||||||||||
net decrease in long term borrowed funds | |||||||||||||||||||||||||||||||||||||||
mortgage servicing asset impairment | 284,000 | -3,972,000 | |||||||||||||||||||||||||||||||||||||
other net gains | 940,000 | ||||||||||||||||||||||||||||||||||||||
repayment of borrowings | -6,000,000 | ||||||||||||||||||||||||||||||||||||||
net decrease in cash and equivalents | -401,248,000 | -31,102,000 | |||||||||||||||||||||||||||||||||||||
mortgage servicing asset (recovery) impairment | -6,000 | ||||||||||||||||||||||||||||||||||||||
net decrease in short term borrowed funds | |||||||||||||||||||||||||||||||||||||||
net increase in long-term borrowed funds | 30,000,000 | ||||||||||||||||||||||||||||||||||||||
net increase in cash and equivalents | 547,566,000 | ||||||||||||||||||||||||||||||||||||||
esop and stock-based compensation plans | 3,631,000 | 2,879,000 | 3,560,000 | ||||||||||||||||||||||||||||||||||||
net gains on the sale of loans | -9,413,000 | -16,372,000 | -3,078,000 | ||||||||||||||||||||||||||||||||||||
principal repayments on and proceeds from sales of loans held for sale and mortgage-backed securities | |||||||||||||||||||||||||||||||||||||||
loans and mortgage-backed securities | |||||||||||||||||||||||||||||||||||||||
loans exchanged for mortgage-backed securities | -79,551,000 | 890,049,000 | 321,024,000 | 250,692,000 | 195,461,000 | 140,607,000 | 230,804,000 | 467,779,000 | |||||||||||||||||||||||||||||||
net increase in short-term federal home loan bank advances | 29,507,000 | ||||||||||||||||||||||||||||||||||||||
net increase in long-term federal home loan bank advances | 20,000,000 | ||||||||||||||||||||||||||||||||||||||
esop shares allocated and committed to be released | |||||||||||||||||||||||||||||||||||||||
net (gain) loss on the sale of loans | -1,255,000 | -1,199,000 | |||||||||||||||||||||||||||||||||||||
private equity fund | |||||||||||||||||||||||||||||||||||||||
net increase in stock subscription proceeds | |||||||||||||||||||||||||||||||||||||||
loan to esop | |||||||||||||||||||||||||||||||||||||||
net increase in short-term advances | 0 | 3,000 | |||||||||||||||||||||||||||||||||||||
esop shares committed to be released | 2,840,000 | ||||||||||||||||||||||||||||||||||||||
contribution of stock to charitable foundation | |||||||||||||||||||||||||||||||||||||||
net income on the sale of loans | 630,000 | -446,000 | 811,000 | ||||||||||||||||||||||||||||||||||||
increase in and death benefits from bank owned life insurance contracts | -1,595,000 | -1,560,000 | -1,565,000 | ||||||||||||||||||||||||||||||||||||
death benefits on bank owned life insurance contracts | |||||||||||||||||||||||||||||||||||||||
net proceeds from sale of common stock | |||||||||||||||||||||||||||||||||||||||
net (decrease) in principal and interest owed on loans serviced | |||||||||||||||||||||||||||||||||||||||
net (decrease) in short-term advances | |||||||||||||||||||||||||||||||||||||||
cash paid for interest on federal home loan bank advances | 314,000 | 308,000 | 311,000 | ||||||||||||||||||||||||||||||||||||
proceeds from sale of loans | -153,680,000 | 360,789,000 | |||||||||||||||||||||||||||||||||||||
proceeds from sale of private equity fund | 0 | 5,009,000 | |||||||||||||||||||||||||||||||||||||
proceeds from sale of fhlb stock |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
